PKC NVR (Rydapt 25 mg)
Generic Name: midostaurin
Pill with imprint PKC NVR is Orange, Capsule-shape and has been identified as Rydapt 25 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Rydapt is used in the treatment of systemic mastocytosis; acute myeloid leukemia and belongs to the drug class multikinase inhibitors. Rydapt 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PKC NVR
Rydapt
- Generic Name
- midostaurin
- Imprint
- PKC NVR
- Strength
- 25 mg
- Color
- Orange
- Size
- 25.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0698
- Inactive Ingredients
-
polyoxyl 40 hydrogenated castor oil,
polyethylene glycol 400,
glycerin,
alcohol,
corn oil,
titanium dioxide,
alpha-tocopherol,
ferric oxide yellow,
ferric oxide red,
carmine,
propylene glycol,
water
Note: Inactive ingredients may vary.
More about Rydapt (midostaurin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.